Freeman, T.J.; Sayedyahossein, S.; Johnston, D.; Sanchez-Pupo, R.E.; O’Donnell, B.; Huang, K.; Lakhani, Z.; Nouri-Nejad, D.; Barr, K.J.; Harland, L.;
et al. Inhibition of Pannexin 1 Reduces the Tumorigenic Properties of Human Melanoma Cells. Cancers 2019, 11, 102.
https://doi.org/10.3390/cancers11010102
AMA Style
Freeman TJ, Sayedyahossein S, Johnston D, Sanchez-Pupo RE, O’Donnell B, Huang K, Lakhani Z, Nouri-Nejad D, Barr KJ, Harland L,
et al. Inhibition of Pannexin 1 Reduces the Tumorigenic Properties of Human Melanoma Cells. Cancers. 2019; 11(1):102.
https://doi.org/10.3390/cancers11010102
Chicago/Turabian Style
Freeman, Taylor J., Samar Sayedyahossein, Danielle Johnston, Rafael E. Sanchez-Pupo, Brooke O’Donnell, Kenneth Huang, Zameena Lakhani, Daniel Nouri-Nejad, Kevin J. Barr, Luke Harland,
and et al. 2019. "Inhibition of Pannexin 1 Reduces the Tumorigenic Properties of Human Melanoma Cells" Cancers 11, no. 1: 102.
https://doi.org/10.3390/cancers11010102
APA Style
Freeman, T. J., Sayedyahossein, S., Johnston, D., Sanchez-Pupo, R. E., O’Donnell, B., Huang, K., Lakhani, Z., Nouri-Nejad, D., Barr, K. J., Harland, L., Latosinsky, S., Grant, A., Dagnino, L., & Penuela, S.
(2019). Inhibition of Pannexin 1 Reduces the Tumorigenic Properties of Human Melanoma Cells. Cancers, 11(1), 102.
https://doi.org/10.3390/cancers11010102